Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Hydroxyapatite (MCHC) vs Vitamin D3: Vitamin D3 has the stronger overall evidence (7.5 vs 4.5/10); they work on different things and are often used together, not either/or. Take the 60-second quiz for a pick tailored to your goals.
Vitamin D3 wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Probably helps
7 of 14 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Hydroxyapatite (MCHC) and Vitamin D3 have evidence — compare verdict strength side-by-side.
3,320 mg of the compound daily, as two 830 mg tablets twice a day (about 712 mg elemental calcium), the regimen of the 3-year osteoporosis trial and the 851-woman cohort. A 6-month pain trial used 1,660 mg a day.
Split doses with meals, Morning and evening
Ossein-hydroxyapatite compound tablets
2000-4000 IU daily
Morning with breakfast
D3 (cholecalciferol) softgel or liquid
and 7 more not shown
and 1 more not shown
With low vitamin D status a smaller share of the calcium is absorbed. Calcium and vitamin D are the combination tested in the osteoporosis trials.
Take together if bone health is the goal. Count the vitamin D in both products toward one daily total.
12-36 months
N/A
Hours to 3 months
5-6 months
4-8 weeks
4-8 weeks
2-4 weeks
4-8 weeks
Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: a meta-analysis.
Menopause (2009) · Meta analysis
Meta-analysis of randomised controlled trials comparing ossein-hydroxyapatite complex (OHC) with calcium carbonate, not with placebo. Of 18 controlled trials identified, 6 were pooled in a random-effects model, and the abstract does not give the total number of participants.
Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females.
Osteoporos Int (1995) · Rct · n=40
Randomised, double-masked trial in 40 women with postmenopausal osteoporosis, each given 1,400 mg calcium a day as either OHC or calcium carbonate for 20 months.
Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.
Clin Drug Investig (2011) · Rct · n=120
Randomised, open-label trial in 120 women over 65 with osteoporosis (55 OHC, 65 calcium carbonate), of whom 54 completed 3 years. OHC gave 712 mg elemental calcium a day and calcium carbonate 1,000 mg, and both groups also took calcifediol.
Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial
Nature communications (2025) · Rct · n=22220
Ancillary analysis of VITAL: 22,220 adults without T2D randomized to vitamin D3 2000 IU/day or placebo, with a meta-analysis of 3 additional trials.
Vitamin D Supplementation for Patients with Dysmenorrhoea: A Meta-Analysis with Trial Sequential Analysis of Randomised Controlled Trials
Nutrients (2024) · Meta analysis · n=687
TSA revealed that the current RCTs provide sufficient information.
Vitamin D and respiratory tract infections
BMJ (2017) · Meta analysis · n=11321
25 RCTs, 11 321 participants aged 0 to 95 years. Vitamin D reduced acute respiratory tract infection overall (adjusted OR 0.88, 95% CI 0.81 to 0.96).
Both points come from a meta-analysis of double-blind cholecalciferol trials in people aged 60 and over (PMID 15886381). Trials at 700 to 800 IU a day cut hip fracture risk by 26% (RR 0.74) and non-vertebral fractures by 23%, plotted at 800 IU. Trials at 400 IU a day showed no benefit (hip fracture RR 1.15), and the WHI trial of 400 IU with 1,000 mg calcium did not significantly reduce hip fracture (PMID 16481635). Most of these trials also gave calcium, and the Cochrane review found vitamin D alone unlikely to prevent fractures while vitamin D with calcium gave a small reduction (PMID 24729336). Doses above 800 IU were not compared, so no optimal dose or ceiling is set.
AI-estimated from published studies. Interpret as directional guidance.
Vitamin D3 has a higher evidence score (7.5/10 vs 4.5/10) and wins in 3 of 3 categories.
For bone health, Vitamin D3 has a higher relevance score (92 vs 55).
Hydroxyapatite (MCHC) and Vitamin D3 may work well together: With low vitamin D status a smaller share of the calcium is absorbed. Calcium and vitamin D are the combination tested in the osteoporosis trials. Take together if bone health is the goal. Count the vitamin D in both products toward one daily total.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Tired? Why most "energy" pills only work if they fix a deficit — and how to find yours first.
Berberine, inositol, magnesium vs the cinnamon/chromium hype — and the med-interaction warning.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.